Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Main text
Springer SU, Chen C-H, Rodriguez Pena MDC, Li L, Douville C, Wang Y, Cohen JD, Taheri D, Silliman N, Schaefer J, Ptak J, Dobbyn L, Papoli M, Kinde I, Afsari B, Tregnago AC, Bezerra SM, VandenBussche C, Fujita K, Ertoy D, Cunha IW, Yu L, Bivalacqua TJ, Grollman AP, Diaz LA, Karchin R, Danilova L, Huang C-Y, Shun C-T, Turesky RJ, Yun BH, Rosenquist TA, Pu Y-S, Hruban RH, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Dickman KG, Netto GJ. 2018. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. eLife 7:e32143. doi: 10.7554/eLife.32143.
Published 20, March 2018
The affiliation of Luis A Diaz was incorrect. The correct affiliation is: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States. In addition, Luis Diaz would like to declare the following for his competing interests statement:
Luis A Diaz (LAD) is a member of the board of directors of Personal Genome Diagnostics (PGDx) and Jounce Therapeutics. LAD holds equity in PapGene, Personal Genome Diagnostics (PGDx) and Phoremost. He is a paid consultant for Merck, PGDx and Phoremost. LAD is an inventor of licensed intellectual property related to technology for ctDNA analyses and mismatch repair deficiency for diagnosis and therapy from Johns Hopkins University. These licenses and relationships are associated with equity or royalty payments to LAD. The terms of all these arrangements are being managed by Johns Hopkins and Memorial Sloan Kettering in accordance with their conflict of interest policies. In addition, in the past 5 years, LAD has participated as a paid consultant for one-time engagements with Caris, Lyndra, Genocea Biosciences, Illumina and Cell Design Labs.
The article has been corrected accordingly.
Article and author information
Author details
Christopher Douville
Joshua David Cohen
Cristian Tomasetti
Publication history
- Version of Record published: November 12, 2018 (version 1)
Copyright
© 2018, Springer et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 409
- Page views
-
- 7
- Citations
Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
eLife 7:e43237.
https://doi.org/10.7554/eLife.43237
